Wellbeing Whisper on MSN

Blood pressure drug recall: What patients should check right now

Not every drug recall signals immediate danger. That distinction matters in the current recall involving bisoprolol fumarate ...
Nasdaq

AstraZeneca Hypertension Drug Baxdrostat Wins FDA Priority Review

(RTTNews) - AstraZeneca's (AZN) New Drug Application (NDA) for experimental hypertension drug baxdrostat has been granted Priority Review by the U.S. Food and Drug Administration. The FDA has set a ...
Morningstar

Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension

AstraZeneca’s New Drug Application (NDA) for baxdrostat has been accepted for Priority Review by the US Food and Drug Administration (FDA) in the US for the treatment of adult patients with ...
The Cardiology Advisor

FDA Grants Review of Lorundrostat NDA for Add-on Hypertension Therapy

The FDA accepts the NDA for lorundrostat, a selective aldosterone synthase inhibitor, for adults with uncontrolled or resistant hypertension.